Cassidy Blundell
Partner at Mission Biocapital
About
A partner based in Cambridge who focuses on new therapeutics investments and portfolio company operations. She holds a PhD in Bioengineering from the University of Pennsylvania and previously completed graduate studies in the HHMI Interfaces program.
Investments
Board seats
Mediar Therapeutics, Inc.Progentos Therapeutics, Inc.
As listed on the firm's website.
Colleagues at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Linda Eng
Director of Operations, Bay Area at Mission Biocapital